Physician profile
Emily Self
NPI 1235822370
$1,267.38
in general payments reported to CMS, 2019-2025
18 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $289 · 2024: $682 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,267.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $405.54 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $171.26 | 2023-2024 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $87.02 | 2024 | Evkeeza |
| Pfizer INC. | $86.40 | 2023 | |
| Amgen INC. | $78.88 | 2023-2024 | Repatha |
| Merck Sharp & Dohme LLC | $73.20 | 2023-2024 | Verquvo |
| Scpharmaceuticals INC. | $71.72 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $45.21 | 2023-2024 | Camzyos |
| Sanofi-Aventis U.S. LLC | $38.69 | 2023-2024 | |
| Novo Nordisk INC | $37.34 | 2024 | |
| United Therapeutics Corporation | $33.78 | 2024 | Tyvaso |
| Esperion Therapeutics, INC. | $23.81 | 2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $22.52 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $22.39 | 2023 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.46 | 2024 | Lifevest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $18.60 | 2025 | Coseal |
| Becton, Dickinson and Company | $18.01 | 2025 | Hemosphere |
| Chiesi USA, INC. | $13.55 | 2023 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Self listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.